about
Rational modulation of the innate immune system for neuroprotection in ischemic strokeNeuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in ratsInhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivationAspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in ratsNeuroprotective effects of aspirin in patients with acute cerebral infarctionRole of nitric oxide after brain ischaemiaImplication of TNF-alpha convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitisPeroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in ratsValidation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia.Neuroprotection and recovery: recent data at the bench on citicoline.Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system.Mitochondrial respiratory chain and free radical generation in stroke.Test repositioning for functional assessment of neurological outcome after experimental stroke in mice.Imaging the role of toll-like receptor 4 on cell proliferation and inflammation after cerebral ischemia by positron emission tomographyMitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications.cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.Cannabinoids: well-suited candidates for the treatment of perinatal brain injury.TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning.TNFR1 upregulation mediates tolerance after brain ischemic preconditioning.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemiamiRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis.Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin.Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model.Targets of cytoprotection in acute ischemic stroke: present and future.3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.L-arginine levels in blood as a marker of nitric oxide-mediated brain damage in acute stroke: a clinical and experimental study.Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia.mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia.Amelioration of ischemic brain damage by peritoneal dialysis.Neutrophils scan for activated platelets to initiate inflammation.TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress.The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury.Correlation between brain nitric oxide synthase activity and opiate withdrawal.L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke.Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.
P50
Q26851831-8D553399-1CFC-4C54-9BC2-270EBFFEFB0CQ28190726-6BF6FC16-26DC-46DB-87EB-C8F3AC083C0EQ28192046-FCB7DFA7-90E7-4F97-AC61-38C4BD360508Q28192533-8E6A6036-2002-4FB1-AA6F-763D6A50780EQ28195362-8CDB4B3F-D107-484E-BAF0-F535B27A786FQ28208960-1E602705-5F93-4536-ADB0-FEC6482FBF55Q28565169-37924301-3D0B-4C6E-8DE4-BFD3054A8102Q28578691-A2ADE548-5651-4E51-B33F-28D840FB7757Q33468639-40CB0FF6-40E2-4105-9BF0-5C54B5DDBAC8Q33773238-E0CA6FB1-E8FD-4273-9D28-94F0690EA7F4Q34234232-4D972E25-3123-4E52-8840-1C6551F774B8Q34390240-A51B72DB-CA61-4EA7-A0E6-52BBE7051603Q35183131-133B46D1-E47A-4BA7-8D98-5539F957B0A2Q36300732-3F8C0064-DDD7-4DF1-9138-6CD75ACAB436Q36363080-9052A42B-4F6C-498E-BED3-B550D021F6C6Q36765878-1D90404E-BE7B-4E90-B5E8-04CE82DDC98CQ37588982-93F806DD-E481-4B1E-995D-5F7F59BD9A99Q37718172-79D73A11-708D-4CC9-B5A7-BCA302C6E284Q38222889-2D669243-D710-4ED9-B0F5-66764D093EB0Q38316350-670395DE-D508-4E3B-923A-6D59D2D2ED8FQ38332109-28872F35-619F-4746-B8DE-7DC24485BB19Q38563981-A04196F1-3348-4B1A-A2CD-276F7B602580Q39144340-E6608C60-7DCE-483A-BCB4-3865D9D03564Q39179831-15DFF1BA-604F-4FA1-80AE-60490E99EFD2Q39335516-113E6D78-B470-492B-90EC-048C82521E15Q39384629-1B5A6885-8492-425B-AAAC-34863C779AACQ39835765-241090ED-3005-4F92-8F2B-AF4C1437C684Q40328996-279125DB-D122-4269-A161-AD320A23A7FBQ40532235-D78ECB69-5610-4D5D-B229-E97B82C6BE8FQ40569887-47C5B0DE-FB44-4CB9-89D8-3559237BAE6CQ40852217-D8764082-7516-483C-8CA2-C7ECCAD9603EQ41770752-91EFD579-3F60-4EC8-B768-AC29AC54A51BQ41905922-665185D6-4628-4065-951F-B859138538A7Q42145294-19130097-5643-4A41-8D16-AB620F01CAF2Q42466055-0932506D-CD4C-4F7E-87C8-E38BA63CC092Q42482647-B8FE96B3-7F72-44E4-8AF0-139E0E2C6C3AQ42547344-6714B16F-0066-4AA2-9A5E-6F4DF8DF9235Q42555542-C3BBFC78-AE71-4A7D-BE11-453CF0F98EC7Q42691044-3289CA29-AA54-499C-B810-2158EEB7C018Q42711833-3A720114-FB4B-4D83-940C-F1F179F204D3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
María A Moro
@ast
María A Moro
@en
María A Moro
@es
María A Moro
@nl
María A Moro
@sl
type
label
María A Moro
@ast
María A Moro
@en
María A Moro
@es
María A Moro
@nl
María A Moro
@sl
prefLabel
María A Moro
@ast
María A Moro
@en
María A Moro
@es
María A Moro
@nl
María A Moro
@sl
P106
P21
P31
P496
0000-0003-1010-8237